Cytonics Corporation

Cytonics is a research and development company dedicated to discovering and developing therapeutics based on the protease inhibitor Alpha2 Macroglobulin (A2M). We are developing a number of A2M therapies with the goal of out-licensing the drugs to strategic partners at the key clinical value inflection points. We maximize the value of the drugs we discover by putting them in the hands of leading pharmaceutical companies with late-stage development, commercialization and marketing expertise. As a result of this strategy, we keep our organization focused with a strong financial position. We have discovered a unique bio-marker that can assist physicians in improving...

A2m therapies,a2m treatments,back and joint pain therapies,treatment for osteoarthritis,biotech,investment opportunity,and equity crowdfunding

Cytonics corporation operates in the Biotechnology industry.

Cytonics corporation's revenue is 11m - 100m

Cytonics corporation has 11 - 50 employees.